RxDoctor Payments Data

Shane Gailushas, MD

Otolaryngology/Facial Plastic Surgery · Cedar Rapids, IANPI 1073786521

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.0%), travel and lodging and other — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Acclarent, Inc at 26.7% of the total.

$5,836in general payments, 2019–2025

Across 130 payments — averaging $44.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$2K
  • Integra Lifesciences Corporation$2K
  • Medical Device Business Services, Inc.$2K
  • Sanofi$251
  • Stryker$204
  • Medtronic$167
  • plus $583 from 15 others

What the payments were for

  • Travel & lodging$1,30522%
  • Food & beverage$3,32557%
  • Other$1,20621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$109,075
Medicare patients
209
Services billed
637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl269$6,172
Ipratropium Bromide98$2,623
Fluticasone Propionate123$1,258
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav61$683
Omeprazole38$451
Mupirocin33$189
Oxycodone Hcl47$188
Montelukast Sodium28$182
Azithromycin27$152
Cefadroxil20$137
Prednisone27$60

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →